Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections. - Orenstein, Robert; Hecht, Gail; Harvey, Adam; Tillotson, Glenn; Khanna, Sahil (Open Forum Infectious Diseases, 2023)